HomeNews

News

  • Anavex to initiate Ph 2 study in Parkinson’s Disease for its drug ANAVEX®2-73

    • April 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Intranasal Esketamine improves Depression symptoms as per latest clinical trial results

    • April 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • GSK Appoints Senior Executive from Roche to Accelerate Pipeline Growth

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Results for Ibudilast Phase II trial in progressive MS to be presented at AAN

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Increasing Prevalence & Incidence rates for Alzheimer’s in Americans, report states

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Biohaven to present additional Phase 3 Rimegepant Data at AAN 2018

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alder to present Phase 3 Eptinezumab results at AAN 2018

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novel Multiple Sclerosis Biomarker to measure severity of disease, suggests study

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Trelegy Ellipta – IMPACT Study Shows Significant Benefits in COPD Patients

    • April 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more